APA (7th ed.) Citation

Hammer, C., Fasching, P. A., Loehberg, C. R., Rauh, C., Ekici, A. B., Jud, S. M., . . . Niesler, B. (2010). Polymorphism in HTR3D shows different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy. Pharmacogenomics, 11(7), . https://doi.org/10.2217/pgs.10.67

Chicago Style (17th ed.) Citation

Hammer, Christian, et al. "Polymorphism in HTR3D Shows Different Risks for Acute Chemotherapy-induced Vomiting After Anthracycline Chemotherapy." Pharmacogenomics 11, no. 7 (2010). https://doi.org/10.2217/pgs.10.67.

MLA (9th ed.) Citation

Hammer, Christian, et al. "Polymorphism in HTR3D Shows Different Risks for Acute Chemotherapy-induced Vomiting After Anthracycline Chemotherapy." Pharmacogenomics, vol. 11, no. 7, 2010, https://doi.org/10.2217/pgs.10.67.